Author:
Bretto Elisabetta,D’Amico Ferdinando,Fiore Walter,Tursi Antonio,Danese Silvio
Abstract
Diverticular disease (DD) is a common gastrointestinal condition. Patients with DD experience a huge variety of chronic nonspecific symptoms, including abdominal pain, bloating, and altered bowel habits. They are also at risk of complications such as acute diverticulitis, abscess formation, hemorrhage, and perforation. Intestinal dysbiosis and chronic inflammation have recently been recognized as potential key factors contributing to disease progression. Probiotics, due to their ability to modify colonic microbiota balance and to their immunomodulatory effects, could present a promising treatment option for patients with DD. Lactobacillus paracasei CNCM I 1572 (LCDG) is a probiotic strain with the capacity to rebalance gut microbiota and to decrease intestinal inflammation. This review summarizes the available clinical data on the use of LCDG in subjects with colonic DD.
Reference97 articles.
1. Pathophysiology and Epidemiology of Diverticular Disease
2. Epidemiology, Pathophysiology, and Treatment of Diverticulitis
3. Diverticular disease practice points;McSweeney;Aust. Fam. Physician,2017
4. Diverticular Disease: An Update on Pathogenesis and Management
5. Clinical analysis of 554 patients with colorectal diverticulosis;Zhang;Zhonghua Wei Chang Wai Ke Za Zhi Chin. J. Gastrointest. Surg.,2021
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献